Aoyama Takashi, Imataki Osamu, Mori Keita, Yoshitsugu Kanako, Fukaya Masafumi, Okamura Ikue, Enami Terukazu, Tatara Raine, Ikeda Takashi
Division of Nutrition, Shizuoka Cancer Center, Shizuoka, Japan.
Division of Hematology & Stem Cell Transplantation, Kagawa University Hospital, Ikenobe Miki Town, Japan.
Ann Hematol. 2017 Apr;96(4):617-625. doi: 10.1007/s00277-016-2910-9. Epub 2017 Jan 3.
Hematopoietic stem cell transplantation carries nutrition-related risks. Therefore, nutritional therapy needs to be initiated before transplantation even takes place. We assessed nutritional risk among patients who underwent allogeneic stem cell transplantation. We assessed nutrient supply (calorie supply and protein supply) by chart review. Assessments were made from the pretreatment phase of transplantation to after the end of parenteral nutrition in 51 patients who underwent allogeneic stem cell transplantation at Shizuoka Cancer Center between 2007 and 2012. We compared nutrition-related adverse events and parameters between two groups: those in whom % loss of body weight was ≥7.5 and those in whom % loss of body weight was <7.5. A correlation was observed between changes in weight and skeletal muscle mass (r = 0.89; P < 0.0001). A weak correlation was observed between % loss of body weight and nutrient supply of calories (r = 0.517; P = 0.0001). There were significant differences between the % loss of body weight ≥7.5 group and the % loss of body weight <7.5 group in the following variables: % loss of body weight, nutrient supply from calories and protein; orally ingested nutrient supply from calories and protein; start day of oral intake; and acute graft-versus-host disease. Orally ingested calories were negatively correlated with nutrition-related adverse events in both groups. Early and customized nutritional intervention may be optimal for all patients who undergo allogeneic stem cell transplantation to ameliorate body weight loss associated with nutrition-related adverse events.
造血干细胞移植存在与营养相关的风险。因此,甚至在移植发生之前就需要开始营养治疗。我们评估了接受异基因干细胞移植患者的营养风险。我们通过病历审查评估营养供应(热量供应和蛋白质供应)。对2007年至2012年在静冈癌症中心接受异基因干细胞移植的51例患者,从移植预处理阶段到肠外营养结束后进行评估。我们比较了两组之间与营养相关的不良事件和参数:体重减轻百分比≥7.5%的患者和体重减轻百分比<7.5%的患者。观察到体重变化与骨骼肌质量之间存在相关性(r = 0.89;P < 0.0001)。观察到体重减轻百分比与热量营养供应之间存在弱相关性(r = 0.517;P = 0.0001)。体重减轻百分比≥7.5%组和体重减轻百分比<7.5%组在以下变量方面存在显著差异:体重减轻百分比、热量和蛋白质的营养供应;口服摄入的热量和蛋白质营养供应;口服摄入开始日;以及急性移植物抗宿主病。两组中口服摄入的热量均与营养相关不良事件呈负相关。对于所有接受异基因干细胞移植的患者,早期和定制的营养干预可能是最佳选择,以改善与营养相关不良事件相关的体重减轻。